Skip to main content
. 2015 Jan 17;7(1):37–45. doi: 10.1016/j.jare.2015.01.003

Table 1.

Total number, recruitment status and funding sources of Egyptian studies in 3 trial registries.

CTGR ICTRP PACTR
n (%) n (%) n (%)
Registry total 163,090 (100.0) 229,638 (100.0) 645 (100.0)
Egypt’s total 548 (0.34) 686 (0.30) 56 (11.30)
Egypt’s rank 115 55 2



Recruitment
Recruiting 150 (27.4) 131 (19.1) 17 (30.4)
Not recruiting 85 (15.5) 508 (74.1) 18 (32.1)
Completed 295 (53.8) 0 (0) 19 (33.9)
Terminated/Withdrawn 18 (3.3) 0 (0) 2 (3.6)
Authorized 0 (0) 45 (6.6) 0 (0)
Not available 0 (0) 2 (0.2) 0 (0)



Results
Available 44 (8.0) a a
Not available 504 (92.0) a a



Funding source
University/Organization 384 (53.8) 262 (38.2) 50 (89.3)
Industry 273 (38.2) 292 (42.6) 0 (0)
Clinical Research Network 25 (3.5) 0 (0) 0 (0)
US Government (excluding U.S. Federal) 15 (2.1) 0 (0) 0 (0)
National Institutes of Health 17 (2.4) 0 (0) 0 (0)
Individual (researcher) 0 (0) 70 (10.2) 6 (10.7)
Other 0 (0) 62 (9.0) 0 (0)

CTGR: U.S. ClinicalTrials.gov Registry, ICTRP: WHO International Clinical Trials Registry Platform, PACTR: Pan-African Clinical Trials Registry.

a

Not included.